A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
Here we present a protocol to induce radiation-induced skin fibrosis in the hind limb of mice and perform post-irradiation measurements of chronic impairment via limb excursion and gait index analyses to evaluate the functional outcome. The model elucidates radiation-related skin fibrosis mechanisms and is useful in subclinical therapeutic studies.
Radiation-induced skin fibrosis (RISF) can result from a plethora of scenarios including cancer therapy, accidental exposure, or acts of terrorism. Radioactive beams can penetrate through the skin and affect the structures in their path including skin, muscles, and internal organs. Skin is the first structure to get exposed to radiation and is susceptible to develop chronic fibrosis, which is challenging to treat. Currently, limited treatment options show moderate efficacy in mitigating radiation-related skin fibrosis. A key factor hindering the development of effective countermeasures is the absence of a convenient and robust model that could allow for translation of the experimental findings to humans. Here, a robust and reproducible murine hind limb skin fibrosis model has been established for prophylactic and therapeutic evaluation of possible agents for functional and molecular recovery.
The right hind limb was irradiated using a single dose of 40 (Gray) Gy to induce skin fibrosis. Subjects developed edema and dermatitis in the early stages proceeded by visible skin constriction. Irradiated limbs showed a significantly reduced limb range of motion in the following weeks. In late stages, acute side effects subsided, yet chronic fibrosis persisted. A gait index was performed as an additional functional assay, which demonstrated the development of functional impairment. These non-invasive methods demonstrated reliable measurements for tracing fibrosis progression, which is supported by histological analyses. The radiation dose, application, and post-irradiation analyses employed in this model offer a vigorous and reproducible method for studying radiation-induced skin fibrosis and testing the efficacy of therapeutical agents.
The skin is the largest organ of the body, covering and protecting the body from hazards. It has three distinct layers: epidermis, dermis, and hypodermis. Each layer has its unique functions: the epidermis prevents dehydration and microbial invasion; the dermis has a rich network of cells, and an extracellular matrix that provides tensile strength and elasticity1; the dermal layer contains the sensory receptors, hair follicles, glands, and vessels for lymphatic and capillary networks. The hypodermis or subcutaneous tissue, with its abundance of adipose tissue, contours the body and distributes mechanical stress2,
Ethical animal use was approved by the Institutional Animal Care and Use Committee (IACUC), which acts in compliance with the Animal Welfare Act. Animals were housed in an Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) approved facility and treated according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
1. Anesthesia
Establishment and optimization of the current irradiation protocol resulted in a consistent and reproducible induction of fibrosis in mice. Right limbs of the mice were positioned and secured within the radiation field on the day of irradiation, and 40 Gy of radiation was administered.
The development of functional impairment in skin was monitored by capturing images every week, post-irradiation. Photos showed that the optimized protocol created fibrosis by day 40 with 95% confidence. An examp.......
Skin injury is a likely outcome of accidental or medical treatment-related exposure to radiation. Nuclear reactors possess an accidental breach risk due to human error or natural disasters like Chernobyl and Fukushima26,27. Therapeutical dosing for cancer treatment is the most common exposure, which uses fractionated repeated dose regimens that risk causing radiation-related fibrosis in the treated areas. This common chronic adverse reaction can be prevalent in u.......
This work is funded by research grants from the Department of Defense W81XWH-19-PRMRP-DA, NIAID/NIH Grant 5R21AI153971-02, and PSF/MTF Grant 603902.
....Name | Company | Catalog Number | Comments |
10% Formalin | Fischer Scientific | 23-427098 | |
Bolus | Orfit | 8333.SO1/R | |
Clipper | Kent Scientific Corp. | CL8787-KIT | |
CO2 | Various | ||
CO2 Chamber | E-Z Systems Inc. | E-22000 | |
Depilatory Cream | Church & Dwight Co., Inc. | Nair | |
Digital Camera | Wolfang | GA100 | |
Eppendrof Tubes | Eppendorf | 22364111 | |
Eye Lubricant | Dechra | Puralube Ophthalmic Ointment | |
Gauze | Covidien | 682252 | |
Image Processing Program | NIH | Image J | |
Isoflurane | Dechra | USP Inhalation Anesthetic | |
Linear Accelaerator | Varian Medical Systems, Inc. | 23EX | |
PBS | Cytiva | SH30256.LS | |
Pentobarbital | Akorn Pharmaceuticals | Nembutal | |
Protractor | Westcott | 550-1120 | |
Small Animal Anesthesia System | E-Z Systems Inc. | EZ-SA800 | Single animal system |
Spreadsheet Software | Microsoft | Excel | |
Surgical Scissors | Medline | MDS0834111 | |
Surgical Tape | 3M | 1538-1 | |
Tape | 3M | H-1113 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved